Inventor

EDGREN DAVID E

US41 patents

⚠️ This page may combine multiple inventors who share the name “EDGREN DAVID E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

EDGREN DAVID E

ALZA CORP

Gastric retention dosage form having multiple layers

Annealed coats

Cellulosic dosage form

Controlled release dosage form comprising different cellulose ethers

Gastric retaining oral liquid dosage form

Controlled release liquid active agent formulation dosage forms

Extended release dosage form

Prolonged release active agent dosage form adapted for gastric retention

Dosage form indicated for the management of abnormal posture, tremor and involuntary movement

Annealed composition for pharmaceutically acceptable drug

Dosage form for Parkinson&#39;s disease, spasticity and muscle spasms

Dosage form comprising drug and maltodextrin

Aqueous based pharmaceutical coating composition for dosage forms

Dosage form for delivering a drug at two different rates

Controlled release liquid active agent formulation dosage forms

Prolonged release active agent dosage form adapted for gastric retention

Dosage form having first and second coats

Active agent dosage form comprising a matrix and at least two insoluble bands

Dosage form for treating central nervous system disorders

Dosage form indicated for the management of abnormal posture, tremor and involuntary movement

Dosage form providing immediate therapy followed by prolonged therapy

Oral osmotic device

Delivery system

Dosage form comprising parallel lamine

Dosage form for delivering acetaminophen or phenylpropanolamine

Dosage form comprising fast agent delivery followed by slow agent delivery

Dosage form comprising means for changing drug delivery shape

Methods for providing effective reboxetine therapy with once-a-day dosing

Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing

Method of fabricating a banded prolonged release active agent dosage form

Stereoisomer therapy

Pharmaceutical coating composition and method of use

SINUSYS CORP

Devices and methods for dilating a paranasal sinus opening and for treating sinusitis

Devices and methods for inserting a sinus dilator

Devices and methods for dilating a paranasal sinus opening and for treating sinusitis

Devices and methods for dilating a paranasal sinus opening and for treating sinusitis

Devices and methods for dilating a paranasal sinus opening and for treating sinusitis

EDGREN DAVID E

Extended release dosage form

Pharmaceutical coating composition and method of use

Sustained release oral dosage forms of an R-baclofen prodrug

SCHRECK THOMAS A

Devices and methods for dilating a paranasal sinus opening and for treating sinusitis

Dosage form for Parkinson's disease, spasticity and muscle spasms